Literature DB >> 16097074

Klatskin tumor treated by inter-disciplinary therapies including stereotactic radiotherapy: a case report.

Gerhild Becker1, Felix Momm, Henning Schwacha, Norbert Hodapp, Henning Usadel, Michael Geissler, Annette Barke, Annette Schmitt-Gräff, Karl Henne, Hubert-E Blum.   

Abstract

In view of the poor prognosis of patients with cholangiocarcinoma (CCC), there is a need for new therapeutic strategies. Inter-disciplinary therapy seems to be most promising. Radiotherapy is an effective alternative to surgery for hilar CCC (Klatskin tumors) if an adequate radiation dose can be delivered to the liver hilus. Here, we describe a patient for whom we used a stereotactic radiotherapy technique in the context of an inter-disciplinary treatment concept. We report a 45-year-old patient with a locally advanced Klatskin tumor. Explorative laparotomy showed that the tumor was not resectable. A metallic stent was implanted and the patient was treated by stereotactic radiotherapy using a body frame. A total dose of 48 Gy (3X4 Gy/wk) was administered. Therapy was well tolerated. After 32 mo, local tumor recurrence and a chest wall metastasis developed and were controlled by radio-chemotherapy. After more than 56 mo with a good quality of life, the patient died of advanced neoplastic disease. Stereotactic radiotherapy led to a long-term survival of this patient with a locally advanced Klatskin tumor. In the context of inter-disciplinary treatment concepts, this radiotherapy technique is a promising choice of treatment for patients with hilar CCC.

Entities:  

Mesh:

Year:  2005        PMID: 16097074      PMCID: PMC4398752          DOI: 10.3748/wjg.v11.i31.4923

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  27 in total

1.  Phase II study of photodynamic therapy and metal stent as palliative treatment for nonresectable hilar cholangiocarcinoma.

Authors:  Franz Ludwig Dumoulin; Thomas Gerhardt; Sybille Fuchs; Christian Scheurlen; Michael Neubrand; Günter Layer; Tilman Sauerbruch
Journal:  Gastrointest Endosc       Date:  2003-06       Impact factor: 9.427

2.  Combined external beam and intraluminal radiotherapy for irresectable Klatskin tumors.

Authors:  Ursula Maria Schleicher; Gundula Staatz; Gerhard Alzen; Demetrios Andreopoulos
Journal:  Strahlenther Onkol       Date:  2002-12       Impact factor: 3.621

Review 3.  Is liver transplantation indicated for cholangiocarcinoma?

Authors:  D R Jeyarajah; G B Klintmalm
Journal:  J Hepatobiliary Pancreat Surg       Date:  1998

Review 4.  Hilar cholangiocarcinoma: a review and commentary.

Authors:  R S Chamberlain; L H Blumgart
Journal:  Ann Surg Oncol       Date:  2000 Jan-Feb       Impact factor: 5.344

5.  Surgical management of 552 carcinomas of the extrahepatic bile ducts (gallbladder and periampullary tumors excluded). Results of the French Surgical Association Survey.

Authors:  R Reding; J L Buard; G Lebeau; B Launois
Journal:  Ann Surg       Date:  1991-03       Impact factor: 12.969

6.  Is liver transplantation indicated for cholangiocarcinoma?

Authors:  R M Goldstein; M Stone; G W Tillery; N Senzer; M Levy; B S Husberg; T Gonwa; G Klintmalm
Journal:  Am J Surg       Date:  1993-12       Impact factor: 2.565

7.  Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction.

Authors:  P H Davids; A K Groen; E A Rauws; G N Tytgat; K Huibregtse
Journal:  Lancet       Date:  1992 Dec 19-26       Impact factor: 79.321

8.  Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients.

Authors:  H Blomgren; I Lax; I Näslund; R Svanström
Journal:  Acta Oncol       Date:  1995       Impact factor: 4.089

9.  Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver.

Authors:  H Bismuth; M B Corlette
Journal:  Surg Gynecol Obstet       Date:  1975-02

Review 10.  Hilar Cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system.

Authors:  E C Burke; W R Jarnagin; S N Hochwald; P W Pisters; Y Fong; L H Blumgart
Journal:  Ann Surg       Date:  1998-09       Impact factor: 12.969

View more
  2 in total

1.  Unresectable hilar cholangiocarcinoma treated with chemoradiotherapy: a 9-year survival case.

Authors:  Takeshi Sakata; Takahiro Yoshikawa; Takeo Nomi; Yasuko Matsuo; Naoki Kamitani; Daisuke Hokuto; Masayuki Sho
Journal:  Int Cancer Conf J       Date:  2020-09-19

Review 2.  Stereotactic radiotherapy in the liver hilum. Basis for future studies.

Authors:  C Zamboglou; M-B Messmer; G Becker; F Momm
Journal:  Strahlenther Onkol       Date:  2011-12-24       Impact factor: 3.621

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.